Millennium Pharmaceuticals, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of medicines for the treatment of cancer in the United States and internationally. It develops and markets VELCADE for injection, a cancer therapy for the treatment of patients with multiple myeloma and relapsed mantle cell lymphoma. The company was founded in 1993 and is headquartered in Cambridge, Massachusetts with facilities in San Diego, San Francisco, Tsukuba, and Osaka. As of May 13, 2008, Millennium Pharmaceuticals, Inc. operates as a subsidiary of Takeda Pharmaceutical Co. Ltd.

Research Grants 40 show all


$123.5K
2005

$204.5K
2006

$119.6K
2007

$131.5K
2008

$109.8K
2009

Publications 107 show all

  • 10
    Factor Xa Inhibitors
  • 10
    Platelet Membrane Glycoproteins/metabolism
  • 7
    Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors
  • 6
    Blood Platelets/physiology
  • 5
    Blood Platelets/metabolism
  • 5
    Peptides/pharmacology
  • 5
    Platelet Aggregation Inhibitors/chemical synthesis
  • 5
    Platelet Aggregation Inhibitors/pharmacology
  • 5
    Platelet Glycoprotein GPIIb-IIIa Complex/metabolism
  • 4
    Thrombin/metabolism

Patents 3,317show all

  • 1,177
    C07K - Peptides
  • 1,141
    A61K - Preparations for medical, dental, or toilet purposes
  • 618
    C12N - Microorganisms or enzymes
  • 452
    C07D - Heterocyclic compounds
  • 369
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 367
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 278
    A01K - Animal husbandry
  • 122
    C07C - Acyclic or carbocyclic compounds
  • 102
    C12Y - Enzymes
  • 65
    Y02A - Technologies for adaptation to climate change

Clinical Trials 737show all

201Phase 2164Phase 3158Phase 1120N/A67Phase 1/Phase 219Other

SEC Filings show all


89
8-K

37
10-Q

10
10-K

1
S-1

Contact Information

40 Landsdowne Street
Cambridge, MA 02139
United States

Overview

Total FundingEmployeesLast Funding DateStatus
1001-5000Acquired